Penn Medicine Provider
Dermatology
Robert G. Micheletti, MD
4.9
(371)
Accepting new patients
Sees patients age 18 and up
Penn Dermatology Perelman
View 1 additional location
Schedule onlineCall 215-662-2737

About me

  • Chief of Hospital Dermatology
  • Chief of Dermatology, Pennsylvania Hospital
  • Director, Cutaneous Vasculitis Clinic, Penn Vasculitis Center
  • Director, Dermatology Medical Student Elective
  • Associate Professor of Dermatology at the Hospital of the University of Pennsylvania
  • Associate Professor of Dermatology in Medicine (General Internal Medicine)

Education and training

  • Medical School: Duke University School of Medicine
  • Residency: Hospital of the University of Pennsylvania

What my patients think about me

Average Rating
4.9

371 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

May 2025
5.0
5.0
very helpful and gets updating on new treatment plans
May 2025
5.0
5.0
dr. micheletti is knowledgeable and cares about his patients
May 2025
5.0
5.0
dr. micheletti is always thoughtful, respectful and responsive to my questions. he explains things well.
May 2025
5.0
5.0
expert care

Insurance accepted

My Locations

Penn Dermatology Pennsylvania Hospital

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Lancaster General Hospital
Dr. Micheletti is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Valdemar Wendelboe Nielsen BSc, Michelle A. Lowes MBBS PhD, Ashley Yates PA, Afsaneh Alavi MD, Richard Flowers MD, Iltefat Hamzavi MD, Joslyn Kirby MD MS Med, Robert Micheletti MD, Christopher Sayed MD, Haley B. Naik MD MHSc A Multi-Site Registry of Patients with Hidradenitis Suppurativa – Insights from HS PROGRESS , Society of Investigative Dermatology: 2025

Radhika Gupta BA, Robert Micheletti MD, Victoria Fang PhD, MD Patient-reported outcomes of glucagon-like peptide-1 agonists on hidradenitis suppurativa severity , Society of Investigative Dermatology: 2025

Alhusayen R, Dienes S, Lam M, Alavi A, Alikhan A, Aleshin M, Bahashwan E, Daveluy S, Goldfarb N, Garg A, Gulliver W, Jaleel T, Kimball AB, Kirchhof MG, Kirby J, Lenczowski J, Lev-Tov H, Lowes MA, Lara-Corrales I, Micheletti R, Okun M, Orenstein L, Poelman S, Piguet V, Porter M, Resnik B, Sibbald C, Shi V, Sayed C, Wong SM, Zaenglein A, Veillette H, Hsiao JL, Naik HB. North American Clinical Practice Guidelines for the Medical Management of Hidradenitis Suppurativa in Special Patient Populations , J Am Acad Dermatol, 92((4)): 2025,825-852

Fang V, Gupta R, Micheletti RG Managing Hidradenitis Suppurativa with Biologics and Small Molecule Inhibitors , Dermatol Clin, 43((2)): 2025,231-245

William Lewis and Robert G Micheletti Dermal Atrophy and Lipoatrophy , Decision-Making in Dermatology: 2025

Robert G Micheletti Cutaneous Vasculitis , Dermatology, 5th Edition: 2025

William Lewis and Robert G Micheletti Epidermal Atrophy , Decision-Making in Dermatology: 2025

Micheletti RG, Rosenbach M, Phillips E, Wintroub B, Shinkai K Cutaneous Drug Reactions , Harrison's Principles of Internal Medicine, 22nd Edition: 2025

Robert G. Micheletti, Luis Requena, and Jeffrey P. Callen Cutaneous Vasculitis and Panniculitis , Rheumatology, 9th Edition: 2025

Wei J, Micheletti RG Hospital Dermatology: Review of Research in 2023-2024 , Cutis, 114((5)): 2024,156-168